243 related articles for article (PubMed ID: 31903673)
1. The effects of different doses of teriparatide on bisphosphonate-related osteonecrosis of the jaw in mice.
Yu W; Su J
Oral Dis; 2020 Apr; 26(3):609-620. PubMed ID: 31903673
[TBL] [Abstract][Full Text] [Related]
2. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.
Ersan N; van Ruijven LJ; Bronckers AL; Olgaç V; Ilgüy D; Everts V
Dentomaxillofac Radiol; 2014; 43(1):20130144. PubMed ID: 24170800
[TBL] [Abstract][Full Text] [Related]
3. Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw.
Kim KM; Park W; Oh SY; Kim HJ; Nam W; Lim SK; Rhee Y; Cha IH
Osteoporos Int; 2014 May; 25(5):1625-32. PubMed ID: 24554340
[TBL] [Abstract][Full Text] [Related]
4. Effects of dexamethasone and nimesulide on bisphosphonate-related osteonecrosis of the jaw: An experimental study.
Oliveira CC; Barros Silva PG; Ferreira AEC; Gonçalves RP; Sousa FB; Mota MRL; Alves APNN
Arch Oral Biol; 2017 Nov; 83():317-326. PubMed ID: 28869827
[TBL] [Abstract][Full Text] [Related]
5. Dental extraction following zoledronate, induces osteonecrosis in rat's jaw.
Vidal-Gutiérrez X; Gómez-Clavel JF; Gaitán-Cepeda LA
Med Oral Patol Oral Cir Bucal; 2017 Mar; 22(2):e177-e184. PubMed ID: 28160593
[TBL] [Abstract][Full Text] [Related]
6. Weekly teriparatide injections successfully treated advanced bisphosphonate-related osteonecrosis of the jaws.
Yoshiga D; Yamashita Y; Nakamichi I; Tanaka T; Yamauchi K; Yamamoto N; Nogami S; Kaneuji T; Mitsugi S; Sakurai T; Kiyomiya H; Tominaga K; Morimoto Y; Takahashi T
Osteoporos Int; 2013 Aug; 24(8):2365-9. PubMed ID: 23371327
[TBL] [Abstract][Full Text] [Related]
7. A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration.
Ohbayashi Y; Iwasaki A; Nakai F; Mashiba T; Miyake M
Osteoporos Int; 2020 Mar; 31(3):577-585. PubMed ID: 31768589
[TBL] [Abstract][Full Text] [Related]
8. Effective ancillary role and long-term course of daily or weekly teriparatide treatment on refractory medication-related osteonecrosis of the jaw: a clinical case series.
Yoshiga D; Yoshioka I; Habu M; Sasaguri M; Tominaga K
Br J Oral Maxillofac Surg; 2022 Jun; 60(5):604-609. PubMed ID: 34996629
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice.
Kuroshima S; Sasaki M; Nakajima K; Tamaki S; Hayano H; Sawase T
Bone; 2018 Jul; 112():177-186. PubMed ID: 29729428
[TBL] [Abstract][Full Text] [Related]
10. Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats.
Barba-Recreo P; Del Castillo Pardo de Vera JL; García-Arranz M; Yébenes L; Burgueño M
J Craniomaxillofac Surg; 2014 Sep; 42(6):744-50. PubMed ID: 24342733
[TBL] [Abstract][Full Text] [Related]
11. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
12. Histopathological Effects of Teriparatide in Medication-Related Osteonecrosis of the Jaw: An Animal Study.
Keskinruzgar A; Bozdag Z; Aras MH; Demir T; Yolcu U; Cetiner S
J Oral Maxillofac Surg; 2016 Jan; 74(1):68-78. PubMed ID: 26215490
[TBL] [Abstract][Full Text] [Related]
13. Bone mineralization and vascularization in bisphosphonate-related osteonecrosis of the jaw: an experimental study in the rat.
Kün-Darbois JD; Libouban H; Mabilleau G; Pascaretti-Grizon F; Chappard D
Clin Oral Investig; 2018 Dec; 22(9):2997-3006. PubMed ID: 29453497
[TBL] [Abstract][Full Text] [Related]
14. The effects of bisphosphonate on the remodeling of different irregular bones in mice.
Su J; Feng M; Han W; Zhao H
J Oral Pathol Med; 2015 Sep; 44(8):638-48. PubMed ID: 25370709
[TBL] [Abstract][Full Text] [Related]
15. Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis.
Dos Santos Ferreira L; Abreu LG; Calderipe CB; Martins MD; Schuch LF; Vasconcelos ACU
Osteoporos Int; 2021 Dec; 32(12):2449-2459. PubMed ID: 34331067
[TBL] [Abstract][Full Text] [Related]
16. Preexisting Periapical Inflammatory Condition Exacerbates Tooth Extraction-induced Bisphosphonate-related Osteonecrosis of the Jaw Lesions in Mice.
Song M; Alshaikh A; Kim T; Kim S; Dang M; Mehrazarin S; Shin KH; Kang M; Park NH; Kim RH
J Endod; 2016 Nov; 42(11):1641-1646. PubMed ID: 27637460
[TBL] [Abstract][Full Text] [Related]
17. Effects of metformin on the prevention of bisphosphonate-related osteonecrosis of the jaw-like lesions in rats.
Nakagawa T; Tsuka S; Aonuma F; Nodai T; Munemasa T; Tamura A; Mukaibo T; Kondo Y; Masaki C; Hosokawa R
J Prosthodont Res; 2021 Jun; 65(2):219-224. PubMed ID: 32938854
[TBL] [Abstract][Full Text] [Related]
18.
Wu S; Li F; Tan J; Ye X; Le Y; Liu N; Everts V; Wan Q
Front Cell Infect Microbiol; 2022; 12():886411. PubMed ID: 35811676
[TBL] [Abstract][Full Text] [Related]
19. The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws: an animal study.
Dayisoylu EH; Şenel FÇ; Üngör C; Tosun E; Çankaya M; Ersöz S; Taskesen F
Int J Oral Maxillofac Surg; 2013 Nov; 42(11):1475-80. PubMed ID: 23746422
[TBL] [Abstract][Full Text] [Related]
20. Management of bisphosphonate-related osteonecrosis of the jaw using teriparatide treatment: A systematic review.
Varoneckas A; Gelažius R; Pliavga V; Leketas M; Kubilius R; Varoneckaitė M
Stomatologija; 2022; 24(3):63-70. PubMed ID: 37140255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
